Amicus Therapeutics, Inc. (FOLD)

Amicus Therapeutics Stock Forecast

Stock Price Forecast

According to 7 professional analysts, the 12-month price target for Amicus Therapeutics stock ranges from a low of $11 to a high of $108. The average analyst price target of $30.29 forecasts a 205.96% increase in the stock price over the next year.

Price Target: $30.29 (+205.96%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$11	$30.29	$19	$108
Change	+11.11%	+205.96%	+91.92%	+990.91%

* Price targets were last updated on Nov 6, 2025.

Analyst Ratings

The average analyst rating for Amicus Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	4	4	4	4	3	2
Buy	4	4	4	4	4	4
Hold	2	2	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	9	9	8	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Anupam Rama JP Morgan	JP Morgan	Buy Maintains $18 → $19	Buy	Maintains	$18 → $19	+91.92%	Nov 6, 2025
Salveen Richter Goldman Sachs	Goldman Sachs	Hold Maintains $9 → $11	Hold	Maintains	$9 → $11	+11.11%	Nov 5, 2025
Gil Blum Needham	Needham	Hold → Strong Buy Upgrades $14	Hold → Strong Buy	Upgrades	$14	+41.41%	Sep 18, 2025
Jeffrey Hung Morgan Stanley	Morgan Stanley	Hold → Buy Upgrades $102 → $108	Hold → Buy	Upgrades	$102 → $108	+990.91%	Jul 17, 2025
Karl Chalabala UBS	UBS	Strong Buy Maintains $21 → $22	Strong Buy	Maintains	$21 → $22	+122.22%	May 2, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

639.89M

Increased by 21.12%

from 528.30M

Revenue Next Year

775.72M

Increased by 21.23%

from 639.89M

EPS This Year

-0.05

from -0.18

EPS Next Year

0.28

from -0.05

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	260.89M	305.51M	329.23M	399.36M	528.30M	639.89M	775.72M
Revenue Growth	43.16%	17.11%	7.76%	21.30%	32.29%	21.12%	21.23%
EPS	-1.07	-0.92	-0.82	-0.51	-0.18	-0.05	0.28
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	34.84
No. Analysts	-	-	-	-	-	12	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	668.9M	819.7M
Avg	639.9M	775.7M
Low	607.1M	721.9M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	26.6%	28.1%
Avg	21.1%	21.2%
Low	14.9%	12.8%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	0.02	0.39
Avg	-0.05	0.28
Low	-0.14	0.17

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.